ClinicalTrials.gg
RecruitingNCT07188870BAMBI2025Updated Nov 17, 2026

Associations of Autistic Traits and Feeding Difficulties

An observational study in Autism Spectrum Disorder (ASD), sponsored by Semmelweis University. Recruiting at 1 site in Hungary. Open to participants aged 18 Months to 6 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by Semmelweis University · Observational

How we know

From the registry’s dates

  • Started Jan 2025; still recruiting 1 year 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
600
Ages
18 Months to 6 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 10 studies in Autism Spectrum Disorder with a site in Hungary — 3 open to participants now, 3 under way, 1 of them phase 3. Autism Spectrum Disorder · Hungary.

Started
2025
the only one that year
Observational
Only one
of the 10
Registered
8th of 10
by date
Lead sponsor
2 of 10
Semmelweis University

Among the 10 studies in Autism Spectrum Disorder with a site in Hungary, this one is the only one that started in 2025, is the only observational one, and was the 8th registered.

Autism Spectrum Disorder

1,733 studies on the registry are indexed under Autism Spectrum Disorder; 503 are open to participants now.

Browse Autism Spectrum Disorder studies →

Open to participants now

3 of the 10 studies in Autism Spectrum Disorder with a site in Hungary are open now. Recruiting first, the newest first:

All 3 open studies →

A study can be open while its sites in Hungary have not opened yet or have stopped. Only those recruiting at a site in Hungary →

Who these studies take

Of the 351 Autism Spectrum Disorder studies recruiting now, 48 (14%) set no upper age limit and 296 (84%) stop at 75 or younger; 301 take children under 18; 92 take healthy volunteers.

This study: 18 Months to 6 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Autism Spectrum Disorder with a site in Hungary, or all of them as a file.
02

Study summary

The objective is to assess the prevalence of autistic traits and feeding disorders in the general population.

Read the detailed description

The objective of our research is twofold:

I. Firstly, the objective is to assess the prevalence of autistic traits and feeding disorders in the general population. The long-term goal is to develop a widely applicable screening tool for early autism detection that can be widely applied by primary care professionals.

  1. To implement this survey, it is necessary to translate, adapt, and validate the screening instruments (questionnaires) into Hungarian.
  2. The objective of the study is to administer the finalised version of the questionnaire to a large sample of parents, with a view to investigating the associations between autism and eating difficulties.

II. Secondly, in the clinical phase of our study, we aim to investigate in greater depth the relationship between feeding difficulties and autism spectrum disorder. In this phase, participants (children in the study group and their parents) will undergo in-person assessments and complete additional questionnaires:

  1. For the objective observation of eating difficulties and autistic symptoms, as well as to compare these findings with earlier responses to the screening questionnaire;
  2. To identify potential additional influencing factors, we will assess the child's somatic status and sensory sensitivities, as well as parental attitudes (e.g., anxiety, attachment, attitudes).
03

Conditions studied

  • Autism Spectrum Disorder (ASD)
04

Who can participate

Ages eligible
18 Months to 6 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Questionnaires will be made available to parents of Hungarian children between 18 - 72 months, diagnosed with ASD by clinicians involved in their care. Parents of neurotypical or undiagnosed children will be reached through social media platforms and via family pediatricians and health visitors in primary care.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age between 1.5 and 6 years
  • Diagnostic status:
  • Diagnosed with autism spectrum disorder;
  • Showing signs of ASD without formal diagnosis;
  • Neurotypical development
  • Children and their parents
  • Parental consent to participate in the study

Exclusion criteria

Exclusion Criteria:

  • Developmental disorders affecting feeding
  • Children living in institutional care separated from parents
  • Medication affecting feeding behavior
  • Malnutrition due to poverty
  • Parents with low educational attainment or severe communication difficulties preventing questionnaire completion
05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
600 participants (estimated)
Patient registry
No

Groups and cohorts

  • BAMBI_pos

    children with BAMBI scores higher than the cut-off

  • BAMBI_neg

    children with BAMBI scores lower than the cut-off

06

What researchers measure

Primary outcomes

  1. Brief Autism Mealtime Behavior Inventory "BAMBI"scores

    Time frame: Cross-sectional study. Through study completion, an average of two years.

07

Study locations

1 of 1 sites recruiting
  • Bethesda Children's Hospital
    Budapest, 1146, Hungary
    Recruiting
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jan 2025 (actual). Primary completion is estimated for Dec 2026, 23 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 25, 2025
First posted
Sep 23, 2025
StartActual
Jan 10, 2025
Primary completionEst.
Dec 31, 2026
CompletionEst.
Sep 30, 2027
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Minor edits
Nothing that changes what the study is or who can join. Edited: verification date
1 update, last Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    Minor edits only
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07188870
Responsible party
Gábor Csukly (Associate Professor, Semmelweis University) — Principal investigator
First posted
Sep 23, 2025
Start date
Jan 10, 2025
Primary completion
Dec 31, 2026 (estimated)
Completion
Sep 30, 2027 (estimated)
Last update
Nov 17, 2026

Study contacts

Krisztina Szalkay, MD
Contact
szalkayk@gmail.com
+36205699044

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion